SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-241695
Filing Date
2005-12-13
Accepted
2005-12-13 16:37:21
Documents
4
Period of Report
2005-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SALIX PHARMACEUTICALS, LTD d8k.htm 8-K 14677
2 LICENSE AND SUPPLY AGREEMENT dex1053.htm EX-10.53 382146
3 PRESS RELEASE dex991.htm EX-99.1 13328
4 GRAPHIC g63873image_1.jpg GRAPHIC 3119
  Complete submission text file 0001193125-05-241695.txt   416183
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 051261359
SIC: 2834 Pharmaceutical Preparations